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BACKGROUND: We examined cervical cancer incidence before and after nationwide cervical cancer screening was initiated in Taiwan in
mid-1995.
RESULTS: The invasive cancer incidence decreased by 47.8% during 1995–2006. The carcinoma in situ incidence increased 1.7-fold
during 1995–2000, and decreased by 19.6% during 2000–2006.
CONCLUSION: The Taiwan national programme has significantly decreased invasive cervical cancer.
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Cervical cancer has been one of the most serious cancers in Taiwan
over the last three decades, accounting for more than 20% of all
female cancers before 2001, and for over 10% of female cancer
deaths before 1995 (Taiwan Cancer Registry Task Force, 1991–
2006). Such reductions following implementation of screening
have been well documented (Peto et al, 2004; Bray et al, 2005). In
Taiwan, Pap smear screening was initiated in December 1974 when
the Cancer Society of the Republic of China together with
gynaecological clinics offered free Pap tests in 1974–1984.
Although the programme was advertised through the mass media,
only 2.4% of women in the first and 4.5% of women in the second 5
years were screened (Chou and Chen, 1989). The National Labor
Insurance began to reimburse the Pap test for all women working
in the private and public sectors in 1991, and the national
screening programme reimbursed by the National Department of
Health was implemented in 1992 with an aim to reimburse Pap
tests for 2% of the women population. The National Health
Insurance was launched in 1995 (Wen et al, 2008), when it started
to reimburse annual Pap tests for all women aged 30 years or more
(Koong et al, 2006). Annual participation gradually increased from
9.4% in 1995 to 27.5% in 2007. But the triennial participation was
only 51.0% during 2005–2007, which was lower than those in most
regions with organised screening programme. All Pap tests are
mandatory to register in the National Cervical Cancer Screening
Registry in Taiwan. Any eligible woman who has not attended for
screening for more than 3 years is urged to attend the screening by
public health nurses of local health centres. Any screened woman
affected with a high-grade squamous intraepithelial or worse lesion
is personally interviewed by public health nurses to check whether
she has received any biopsy, follow-up Pap test, and treatment.
The specific aim of this study is to evaluate whether the disease
burden of cervical cancer changed with the implementation of
national screening programme in Taiwan, where the screening
participation was lower than those in other countries with
organised screening programme.
MATERIALS AND METHODS
In this study, cervical cancer incidence and mortality data were
derived from several national registries. Population numbers
during 1991–2007 were obtained from National Household
Registry profiles (Department of Household Registration, 1991–
2007); this was found to be complete (99.3%) according to the 2000
census in Taiwan (Chen and Liu, 2002).
National Cancer Registry in Taiwan was launched in 1979 to
collect information of all incident cancer cases from hospitals with
50 or more beds. It was considered a complete and accurate
registry with a percentage of cases based on death certificate only
(DCO) as low as 3.9% in 2000 and 1.8% in 2005. The DCO
percentage for cervical cancer was o1% after 2000, and the
percentage of morphological verification of cervical cancer was
more than 90% after 2002 (Taiwan Cancer Registry Task Force,
1991–2006). The numbers of incident cases of cervical cancer
(International Classification of Diseases for Oncology Field Trial
Edition (ICD-O-FT) coded 180 during 1991–2001, and ICD-O
Third Edition (ICD-O-3) (Fritz et al, 2000) coded C53 after 2002)
were obtained from National Cancer Registry profile during 1991–
2006. The invasive cancer and carcinoma in situ were differ-
entiated according to the ICD-O-FT or ICD-O-3 morphology fifth
digit behaviour code for neoplasms. The identification of cancer
cell type was according to ICD-O-FT or ICD-O-3 morphology code.
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1995, covering 90–98% of the general population; it started to
reimburse annual conventional Pap smear for women over 30
years of age in 1995. The National Cervical Cancer Screening
Registry was also launched in 1995 to evaluate the efficacy and
effectiveness of the programme. All Pap smears were reviewed
according to 2001 Bethesda system (Solomon et al, 2002), and any
high-grade lesion or worse detected was automatically referred to
the follow-up system. Registration of the Pap test records was
mandatory, and 24 million screening records were reported from
100 laboratories from 1995 to 2007. There were 5.6 million eligible
women who participated in the screening programme at least once.
Annual, triennial, and 5-year numbers of screening participants
were derived from the NCCSR profiles during 1995–2007.
RESULTS
In Taiwan, there were 1800–3000 newly diagnosed cases of
invasive cervical cancer cases, and 700–4000 newly diagnosed
cases of carcinoma in situ in each year during the period from 1991
to 2007. The annual, triennial, and 5-year cervical cancer screening
participation in Taiwan from 1995 to 2007 are shown in Figure 1.
The annual participation gradually increased from 9.4% in 1995 to
27.5% in 2007, triennial participation increased from 33.9% in
1997 to 51.0% in 2007, and 5-year participation increased from
53.6% in 1999 to 63.5% in 2007. After the implementation of the
screening programme in 1995, around 75% eligible women in
Taiwan had participated in the programme for at least once
by 2007.
The secular trends of age-standardised cervical cancer incidence
for women aged 30 years or more in Taiwan are shown in Figure 2.
Age-adjusted incidence of carcinoma in situ per 100000 women
increased from 15.8 in 1991 to 23.9 in 1995. Age-adjusted incidence
of invasive cancer increased in the first year after the implementa-
tion of screening programme, and then decreased from 57.8 in
1996 to 26.2 in 2006 (54.7% reduction). Age-adjusted incidence of
carcinoma in situ per 100000 women increased from 23.9 in 1995
to 69.2 in 1999, and then decreased from 69.2 to 52.4 (24.3%
reduction). The age-adjusted incidence of invasive cancer and
carcinoma in situ rapidly reduced in 2003 and rebounded in 2004
might be due to reduction in screening and confirmatory diagnosis
of cervical cancers because of the outbreak of severe acute
respiratory syndrome in 2003 in Taiwan.
The incidence of invasive cervical cancer did not decrease
significantly in age groups of 30–69 years until 1997 and in age
group of 70þ years until 1999. The reduction percentage of
incidence of invasive cervical cancer from 1995 to 2006 was 47.5%
(from 20.0 to 10.5), 41.9% (from 43.2 to 25.1), 54.8% (from 67.7 to
30.6), 55.5% (from 83.1 to 37.0), and 32.3% (from 77.1 to 52.2),
respectively, for age group of 30–39, 40–49, 50–59, 60–69, and
70þ years. The incidence of carcinoma in situ increased rapidly
after 1995, picked at 1999, and then reduced in most age groups
except the age group of 30–39 years.
The main morphological type of invasive cervical cancer in
Taiwan was squamous cell carcinoma, but the proportion of
adenocarcinoma increased from 5.5% in 1991 to 13.7% in 2006.
The incidence of invasive cervical squamous cell carcinoma
decreased from 1995 to 2006 showing a reduction percentage of
55.6% (from 16.0 to 7.1), 48.1% (from 34.1 to 17.7), 58.5% (from
56.2 to 23.3), 53.7% (from 67.2 to 31.1), and 31.0% (from 64.2 to
44.3 per 100000), respectively, for age groups of 30–39, 40–49,
50–59, 60–69, and 70þ years. The incidence of invasive cervical
adenocarcinoma decreased from 2000 to 2006 showing a reduction
percentage of 15.4% (from 2.6 to 2.2), 31.3% (from 6.4 to 4.4),
21.0% (from 6.2 to 4.9), 31.9% (from 4.7 to 3.2), and 7.9% (from 3.8
to 3.5 per 100000), respectively, for age groups of 30–39, 40–49,
50–59, 60–69, and 70þ years.
DISCUSSION
The study provided evidence that national organised screening
programme significantly reduced cervical cancer risk in Taiwan.
We used several complete and accurate national databases to
assess efficacy. The significant rapid and gradual reduction obser-
ved in this study was obviously attributable to the programme.
Organised cervical cancer screening is well-known to effectively
reduce invasive cancer incidence in developed countries, and
consistent findings were observed in this study. There was 48.0%
reduction in invasive cancer incidence from 1995 to 2006 in
women with an average triennial screening participation of 53.4%
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Figure 1 Annual, triennial, 5-year interval, and cumulative cervical cancer screening participation rate for women aged 30 years or more from 1995 to
2007 in Taiwan.
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the national screening programme, the rapid reduction after the
screening programme provides evidence for its efficacy.
The screening may decrease the incidence of invasive cancer by
detecting precancerous lesions. The incidence of invasive cancer in
regions with more than 70% triennial screening participation
reduced at least 35% after 10 years of organised screening, but 52%
triennial participation in Taiwan only reduced 28.9% (Anttila et al,
2004). It is also worth to note that under the low participation, the
incidence of cervical carcinoma in situ also significantly reduced in
all age groups older than 35 years.
In this study, the screening programme significantly reduced the
incidence of squamous cell carcinoma and adenocarcinoma in all
age groups. A recent study of cervical adenocarcinoma incidence
in 13 European countries (Bray et al, 2005) found a decline in the
United Kingdom, Denmark, and Sweden in the 1990s, primarily
among women aged 30 years or more, and an increase in other
countries. Improvements of Pap smear technique, such as the
extended tip spatula or the endocervical brush, have aided general
practitioners to collect inner cervix cells (Buntinx and Brouwers,
1996). However, the reduction in cervical adenocarcinoma
incidence was not observed in all regions where extended tip
spatula was generally used (Visioli et al, 2004). The awareness of
adenocarcinoma in situ as precancerous lesions facilitated early
detection of malignant lesions (Mitchell et al, 2004) with
consequently increased incidence of adenocarcinoma. In Taiwan,
the incidence of cervical adenocarcinoma increased for several
years after the screening programme was implemented, and then
reduced slightly. Whether this significantly reduces cervical
adenocarcinoma incidence needs a longer time to determine.
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Figure 2 Secular trends of age-standardised rate for cervical cancer mortality, invasive cervical cancer, and cervical carcinoma in situ for women aged 30
years or more from 1991 to 2007 in Taiwan.
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